WebNov 1, 2015 · In this review, we discuss the swallowing structures responsible for functional impairment, analyse the studies that have explored the dose–response relationship between these critical structures and late dysphagia, and consider the merits of reported dysphagia-optimised IMRT (Do-IMRT) approaches, thus far. WebJun 8, 2024 · DO-IMRT, which has been pioneered by researchers from The Royal Marsden Hospital and The Institute of Cancer Research, London, is optimised to reduce the risk of swallowing difficulties, known as dysphagia. It does this by reducing radiation to the pharyngeal muscles, which support swallowing.
Dysphagia-optimised Intensity-modulated Radiotherapy …
WebJan 1, 2024 · The long-term swallowing outcomes of this novel technique were only slightly worse compared to baseline, suggesting potential functional improvements aimed at reducing dysphagia. A phase III randomised multicenter study [27] of dysphagia-optimised IMRT versus standard IMRT in HNC is currently in progress. The study aims … WebOct 6, 2016 · The aim of Dysphagia/Aspiration at risk structures (DARS) trial is to determine whether reducing the dose to the pharyngeal constrictors with dysphagia-optimised … ipad air reagiert nicht mehr
Results of a randomized phase III study of dysphagia-optimized ...
WebThe results of the DARS study by Nutting et al. clarified the advantage of limiting the mean doses to key swallowing structures like the pharyngeal constrictors with a significant reduction in patient reported swallowing difficulties … WebJun 14, 2024 · Purpose Dysphagia is one of the most important treatment-related side effects in head and neck cancer (HNC), as it can lead to severe life-threating complications such as aspiration pneumonia and malnutrition. Intensity-modulated radiotherapy (IMRT) could reduce swallowing dysfunction by producing a concave dose distribution and … WebSep 9, 2024 · DARS (ISRCTN:25458988) tested if using DO-IMRT to reduce RT dose to the dysphagia/aspiration related structures (DARS) improved swallowing function compared to S-IMRT. Materials and Methods Patients with T1-4, N0-3, M0 OPC/HPC were randomised 1:1 to S-IMRT (65 Gray (Gy)/30 fractions (f) to primary & nodal tumour; 54 Gy/ 30f to … openlayers popup react